Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

CD4+CD25high regulatory cells in peripheral blood of NSCLC patients.

CD4+CD25high regulatory cells in peripheral blood of NSCLC patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • CD4+CD25high regulatory cells in peripheral blood of NSCLC patients. Abstract Text:

    li liuLi Liu,junxia yaoJunxia Yao,qian dingQian Ding,shiang huangShiang Huang,

    The proportion and changes of CD4+CD25high regulatory T cells (Trs) in peripheral blood of non-small cell lung cancer (NSCLC) patients were analyzed and their clinical significance explored. The peripheral blood was collected from 61 patients with NSCLC and 15 healthy controls. By using monoclonal antibodies, the blood samples were evaluated with the flow cytometry for lymphocyte subsets (CD3+, CD4+ and CD8+) and CD4+CD25high Tr cells. The results showed that the proportion of CD4+CD25high Tr cells in NSCLC group was significantly higher than in control group [(4.36 +/-2.07) % vs (2.04+/-1.03) %, P<0.01]. The proportion of CD4+CD25 high Tr cells in late stage was higher than that in early stage [stages I +II (2.26+/-0.6) %; stage III (3.28+/-1.38) %; stage IV (6.06 +/-4.08) %] (P<0.05). Kaplan-Meier survival analysis revealed that the prognosis of the patients who had higher proportion of CD4+CD25high Tr cells in peripheral blood was worse (P=0.0026). In conclusion, the relative increase in CD4+CD25high Tr cells in peripheral blood may be related to immunosuppression and tumor progression in patients with NSCLC. This finding suggests that CD4+CD25+high Tr cells in peripheral blood of NSCLC may be positive for prognosis analysis. The use of depletion of the CD4+CD25high Tr cell therapy to treat NSCLC patients may be an effective strategy.

    CD4+CD25high regulatory cells in peripheral blood of NSCLC patients. Publishing Authors By Initials

    l liuL Liu,j yaoJ Yao,q dingQ Ding,s huangS Huang,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    CD4+CD25high regulatory cells in peripheral blood of NSCLC patients. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of Huazhong University of Science and Tech

    VOLUME: 26

    Page Numbers: 548-51

    Journal Abbreviation: J. Huazhong Univ. Sci. Technol

    ISSN: 1672-0733

    DAY: 15

    MONTH: 01

    YEAR: 2006

    CD4+CD25high regulatory cells in peripheral blood of NSCLC patients. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101169627

    CD4+CD25high regulatory cells in peripheral blood of NSCLC patients. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: CD4+CD25high regulatory cells in peripheral blood of NSCLC patients. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for CD4+CD25high regulatory cells in peripheral blood of NSCLC patients.

    AFFILIATION: Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430023, China.

    Country: China

    China Research PublicationChina Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Huazhong Univ Sci Technolog

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    CD4+CD25high regulatory cells in peripheral blood of NSCLC patients Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News